F

Fulgent Genetics
D

FLGT

17.880
USD
-0.47
(-2.56%)
Market Closed
Volume
7,279
EPS
0
Div Yield
-
P/E
-3
Market Cap
546,892,181
Related Instruments
    A
    ABEO
    -0.09500
    (-1.60%)
    5.85500 USD
    B
    BEAM
    -2.275
    (-8.65%)
    24.035 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    M
    MESO
    -1.280
    (-11.32%)
    10.030 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    V
    VCEL
    -0.240
    (-0.46%)
    52.510 USD
    More
News

Title: Fulgent Genetics

Sector: Healthcare
Industry: Diagnostics & Research
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.